Candel Therapeutics Inc
NASDAQ:CADL
Balance Sheet
Balance Sheet Decomposition
Candel Therapeutics Inc
Candel Therapeutics Inc
Balance Sheet
Candel Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
5
|
35
|
83
|
70
|
35
|
103
|
|
| Cash Equivalents |
5
|
35
|
83
|
70
|
35
|
103
|
|
| Short-Term Investments |
40
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
1
|
1
|
|
| Total Current Assets |
45
|
35
|
85
|
72
|
37
|
104
|
|
| PP&E Net |
0
|
3
|
4
|
5
|
4
|
3
|
|
| PP&E Gross |
0
|
3
|
4
|
5
|
4
|
3
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
46
N/A
|
38
-17%
|
89
+133%
|
78
-13%
|
41
-47%
|
107
+159%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
1
|
2
|
0
|
0
|
0
|
|
| Accrued Liabilities |
1
|
3
|
3
|
5
|
5
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
9
|
10
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
22
|
|
| Total Current Liabilities |
1
|
5
|
5
|
6
|
14
|
38
|
|
| Long-Term Debt |
0
|
0
|
1
|
21
|
12
|
3
|
|
| Other Liabilities |
3
|
8
|
19
|
4
|
2
|
0
|
|
| Total Liabilities |
5
N/A
|
13
+162%
|
25
+96%
|
30
+20%
|
28
-5%
|
41
+42%
|
|
| Equity | |||||||
| Common Stock |
49
|
49
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
26
|
44
|
80
|
99
|
137
|
192
|
|
| Additional Paid In Capital |
18
|
20
|
144
|
147
|
150
|
259
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
41
N/A
|
25
-38%
|
64
+152%
|
48
-26%
|
13
-73%
|
66
+420%
|
|
| Total Liabilities & Equity |
46
N/A
|
38
-17%
|
89
+133%
|
78
-13%
|
41
-47%
|
107
+159%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
28
|
28
|
29
|
29
|
29
|
47
|
|